Biotech

Alzheimer's Therapeutics Reviewed by NeuroPerspective

CARDIFF, CA: ...

Dynavax Reports Modified Intent to Treat Analysis From the HEPLISAV(TM) Phase 3 Trial in Healthy Adults Over Age 40

BERKELEY, CA: ...

Paladin Labs Advises That A Condition of Its Offer for Afexa Life Sciences Cannot Be Fulfilled

MONTREAL, CANADA: - No Shares Will Be Taken Up ...

Cellceutix's Drug Discovery Is a Major Leap Forward in the Fight Against Cancer

BEVERLY, MA: Drug Delivery Devices Received From Hospital and Stability Studies Underway ...

Nerium Biotechnology, Inc. Completes US$250,000 Private Placement

SAN ANTONIO, TEXAS: ...

NuPathe to Present at the Safeguard Scientifics Investor Day 2011

CONSHOHOCKEN, PA: ...

Ceapro Files Statement of Defence

EDMONTON, ALBERTA: ...

Easton Pharmaceuticals Strengthens Sales Capabilities With Key Management Team Addition

TORONTO, ONTARIO: John Mitchell, Noted Pharmaceutical Sales and Marketing Professional, Accepts Position as Vice President of Sales-North America ...

Peregrine Completes Patient Enrollment in Randomized Phase II HCV Trial for Bavituximab

TUSTIN, CA: HCV Trial Evaluating 12 Weeks of Therapy With Bavituximab With Ribavirin; Early Virologic Response (EVR) Data Expected by End of 2011 or Early 2012 ...

Warnex Bioanalytical Services Receives DEQAS Certification for Vitamin D Analysis

LAVAL, QUEBEC: ...